Fungal infections have become a significant health concern, especially among immunocompromised individuals. Traditional treatments like azoles and echinocandins face challenges such as resistance, toxicity, and limited spectrum of activity. As a result, new antifungal agents are required to overcome these hurdles and provide more effective treatment options.
